Cargando…

Human Trabecular Meshwork Progenitors

Trabecular meshwork (TM) cells are a group of progenitors that have the ability to become adipocytes, chondrocytes and endothelial cells. Therefore, those adult corneal progenitors may be used as an effective therapy for trabecular meshwork diseases such as glaucoma, corneal endothelial dysfunctions...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qin, Zhang, Yuan, Tighe, Sean, Liu, Yongsong, Zhu, Yingting, Hu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566744/
https://www.ncbi.nlm.nih.gov/pubmed/31217738
http://dx.doi.org/10.7150/ijms.32089
_version_ 1783426918920486912
author Zhu, Qin
Zhang, Yuan
Tighe, Sean
Liu, Yongsong
Zhu, Yingting
Hu, Min
author_facet Zhu, Qin
Zhang, Yuan
Tighe, Sean
Liu, Yongsong
Zhu, Yingting
Hu, Min
author_sort Zhu, Qin
collection PubMed
description Trabecular meshwork (TM) cells are a group of progenitors that have the ability to become adipocytes, chondrocytes and endothelial cells. Therefore, those adult corneal progenitors may be used as an effective therapy for trabecular meshwork diseases such as glaucoma, corneal endothelial dysfunctions such as blindness due to corneal endothelial dysfunction, and similar diseases. In order to promote the understanding of human trabecular meshwork progenitors, this article reviews human trabecular meshwork progenitor therapy and discusses its potential applications for curing human eye blindness.
format Online
Article
Text
id pubmed-6566744
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-65667442019-06-19 Human Trabecular Meshwork Progenitors Zhu, Qin Zhang, Yuan Tighe, Sean Liu, Yongsong Zhu, Yingting Hu, Min Int J Med Sci Review Trabecular meshwork (TM) cells are a group of progenitors that have the ability to become adipocytes, chondrocytes and endothelial cells. Therefore, those adult corneal progenitors may be used as an effective therapy for trabecular meshwork diseases such as glaucoma, corneal endothelial dysfunctions such as blindness due to corneal endothelial dysfunction, and similar diseases. In order to promote the understanding of human trabecular meshwork progenitors, this article reviews human trabecular meshwork progenitor therapy and discusses its potential applications for curing human eye blindness. Ivyspring International Publisher 2019-05-10 /pmc/articles/PMC6566744/ /pubmed/31217738 http://dx.doi.org/10.7150/ijms.32089 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Review
Zhu, Qin
Zhang, Yuan
Tighe, Sean
Liu, Yongsong
Zhu, Yingting
Hu, Min
Human Trabecular Meshwork Progenitors
title Human Trabecular Meshwork Progenitors
title_full Human Trabecular Meshwork Progenitors
title_fullStr Human Trabecular Meshwork Progenitors
title_full_unstemmed Human Trabecular Meshwork Progenitors
title_short Human Trabecular Meshwork Progenitors
title_sort human trabecular meshwork progenitors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566744/
https://www.ncbi.nlm.nih.gov/pubmed/31217738
http://dx.doi.org/10.7150/ijms.32089
work_keys_str_mv AT zhuqin humantrabecularmeshworkprogenitors
AT zhangyuan humantrabecularmeshworkprogenitors
AT tighesean humantrabecularmeshworkprogenitors
AT liuyongsong humantrabecularmeshworkprogenitors
AT zhuyingting humantrabecularmeshworkprogenitors
AT humin humantrabecularmeshworkprogenitors